Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP434104.RAcDNKl4OcCUO3frGLOMvqH51Mf0z6ZBpXhK2_dVX8hS4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP434104.RAcDNKl4OcCUO3frGLOMvqH51Mf0z6ZBpXhK2_dVX8hS4130_assertion type Assertion NP434104.RAcDNKl4OcCUO3frGLOMvqH51Mf0z6ZBpXhK2_dVX8hS4130_head.
- NP434104.RAcDNKl4OcCUO3frGLOMvqH51Mf0z6ZBpXhK2_dVX8hS4130_assertion description "[We undertook a case-control study of 212 (BC) cases and 250 controls to investigate the association between Caspase 9-1263A > G, Caspase 9-293del, and Caspase 8-6 N ins/del polymorphism and BC susceptibility by polymerase chain reaction (PCR) restriction fragment length polymorphism (RFLP) method, and further to study the influence on recurrence in patients after Bacillus Calmette-Guerin (BCG) immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434104.RAcDNKl4OcCUO3frGLOMvqH51Mf0z6ZBpXhK2_dVX8hS4130_provenance.
- NP434104.RAcDNKl4OcCUO3frGLOMvqH51Mf0z6ZBpXhK2_dVX8hS4130_assertion evidence source_evidence_literature NP434104.RAcDNKl4OcCUO3frGLOMvqH51Mf0z6ZBpXhK2_dVX8hS4130_provenance.
- NP434104.RAcDNKl4OcCUO3frGLOMvqH51Mf0z6ZBpXhK2_dVX8hS4130_assertion SIO_000772 19412632 NP434104.RAcDNKl4OcCUO3frGLOMvqH51Mf0z6ZBpXhK2_dVX8hS4130_provenance.
- NP434104.RAcDNKl4OcCUO3frGLOMvqH51Mf0z6ZBpXhK2_dVX8hS4130_assertion wasDerivedFrom befree-20140225 NP434104.RAcDNKl4OcCUO3frGLOMvqH51Mf0z6ZBpXhK2_dVX8hS4130_provenance.
- NP434104.RAcDNKl4OcCUO3frGLOMvqH51Mf0z6ZBpXhK2_dVX8hS4130_assertion wasGeneratedBy ECO_0000203 NP434104.RAcDNKl4OcCUO3frGLOMvqH51Mf0z6ZBpXhK2_dVX8hS4130_provenance.